𝔖 Bobbio Scriptorium
✦   LIBER   ✦

6593 POSTER Nerve growth factor (NGF) levels in plasma in patients with advanced non-small cell lung cancer patients (NSCLC). Is it predictive of clinical outcome?

✍ Scribed by Sirera, R.; Camps, C.; Caballero, C.; Safont, M.J.; Blasco, A.; Gavila, J.; Cabrera-Pastor, A.; Iranzo, V.; Taron, M.; Rosell, R.


Book ID
123307632
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
57 KB
Volume
5
Category
Article
ISSN
1359-6349

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Reaction of plasma hepatocyte growth fac
✍ Hidenori Tanaka; Tatsuo Kimura; Shinzoh Kudoh; Shigeki Mitsuoka; Tetsuya Watanab πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 French βš– 242 KB

## Abstract Hepatocyte growth factor induces resistance to epidermal growth factor receptor tyrosine kinase inhibitors. It has been hypothesized that epidermal growth factor receptor tyrosine kinase inhibitors administration may influence the levels of plasma hepatocyte growth factor. Patients with